Amneal Pharmaceuticals, Inc.AMRXNASDAQ
LOADING
|||
EV to Sales: Discounted Valuation
Trending higher, below historical average, structural decline.
Left:
||||
Enterprise value to sales ratio
Latest
1.76
↓ 41% below average
Average (9y)
2.98
Historical baseline
Range
High:10.43
Low:1.41
CAGR
-17.9%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | 1.76 | +13.5% |
| 2023 | 1.55 | +10.2% |
| 2022 | 1.41 | -11.7% |
| 2021 | 1.60 | -4.8% |
| 2020 | 1.68 | -16.3% |
| 2019 | 2.00 | -20.7% |
| 2018 | 2.53 | -21.4% |
| 2017 | 3.21 | -10.9% |
| 2016 | 3.61 | -65.4% |
| 2015 | 10.43 | - |